Onderneming NovoCure Limited
Aandelen
NVCR
JE00BYSS4X48
Medische apparatuur, benodigdheden & distributie
Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
12,06 USD | +1,90% | -3,25% | -19,26% |
10/04 | NOVOCURE LIMITED : Piper Sandler ontvangt een koopadvies | ZM |
05/04 | NovoCure zegt dat nieuwe gegevens de potentiële therapeutische effecten van TTFields bij alvleesklierkanker aantonen | MT |
Vakgebied
Aantal werknemers: 1 453
Verkoop per activiteit
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Tumor Treating Fields
100,0
%
| 538 | 100,0 % | 509 | 100,0 % | -5,30% |
Verkoop per regio
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
United States
68,7
%
| 407 | 75,7 % | 350 | 68,7 % | -14,05% |
Germany
11,8
%
| 46 | 8,6 % | 60 | 11,8 % | +30,55% |
Others
8,7
%
| 0 | 0,0 % | 44 | 8,7 % | - |
Japan
6,2
%
| 33 | 6,1 % | 32 | 6,2 % | -3,40% |
Greater China
4,6
%
| 21 | 4,0 % | 23 | 4,6 % | +8,87% |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Asaf Danziger
CEO | Chief Executive Officer | 56 | 01-01-02 |
Ashley Cordova
DFI | Director of Finance/CFO | 45 | 01-06-14 |
Moshe Giladi
CTO | Chief Tech/Sci/R&D Officer | - | - |
Nicolas Leupin
CTO | Chief Tech/Sci/R&D Officer | 50 | 04/01 |
Chief Operating Officer | 66 | 05-01-12 | |
Ingrid Goldberg
IRC | Investor Relations Contact | - | 01-07-21 |
Barak Ben Arye
LAW | General Counsel | 48 | 01-01-18 |
Corporate Officer/Principal | - | - | |
Uri Weinberg
PRN | Corporate Officer/Principal | 46 | 01-03-08 |
Michael Puri
HRO | Human Resources Officer | 55 | 01-09-23 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Bill Doyle
CHM | Chairman | 61 | 01-01-04 |
Kin Yip Leung
BRD | Director/Board Member | 62 | 05-08-11 |
David Hung
BRD | Director/Board Member | 66 | 31-05-18 |
Timothy Scannell
BRD | Director/Board Member | 60 | 05-02-21 |
Jeryl Hilleman
BRD | Director/Board Member | 66 | 25-07-18 |
Tony Vernon
BRD | Director/Board Member | 68 | 01-01-06 |
Asaf Danziger
CEO | Chief Executive Officer | 56 | 01-01-02 |
Martin Madden
BRD | Director/Board Member | 64 | 10-05-17 |
Kristin Stafford
BRD | Director/Board Member | 42 | 28-03-23 |
Allyson Ocean
BRD | Director/Board Member | 52 | 23-02-23 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 107 093 432 | 105 308 013 ( 98,33 %) | 0 | 98,33 % |
Bedrijfsgegevens
NovoCure Ltd.
No. 4 The Forum Grenville Street
JE2 4UF, St. Helier
+44 15 3475 6700
http://www.novocure.comSector
Verkoop per regio
Herzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
-19,26% | 1,3 mld. | |
+72,39% | 12,32 mld. | |
-18,22% | 7,96 mld. | |
+16,84% | 7,25 mld. | |
+2,94% | 5,84 mld. | |
+8,16% | 5,11 mld. | |
+19,97% | 4,28 mld. | |
-19,84% | 4 mld. | |
-42,79% | 2,15 mld. | |
+1,11% | 2,01 mld. |
- Beurs
- Aandelen
- Koers NVCR
- Onderneming NovoCure Limited